Table 2. Study Protocol.

(*denotes data are collected, but is secondary outcome)

	Study period
		Enrollment	Allocation	Post-allocation				Exit
Time point	−T2	−T1	T0	T1 (4 wks)	T2 (8 wks)	T3 (12 wks)	T4 (16 wks)	T5 (20 wks)
Eligibility screening
Phone screening	X
In-person screening
10M walk		X
90 sec balance		X
Informed consent		X
Run-In Period
Vision screen		X
Medication review		X
Home safety check		X
Allocation			X
Intervention
Active Control				XXXXXXX	XXXXXXX	XXXXXXX	XXXXXXX
Web-based Cognitive Training				XXXXXXX	XXXXXXX	XXXXXXX	XXXXXXX
Assessments
Baseline
Demographics		X
Pre-existing conditions		X
Medications		X
Social Support		X
Outcome Variables
Primary
Falls/Injurious Falls				X	X	X	X	*
Secondary
Fall Risk
10M walk		X			X		X	X
90 sec balance		X			X		X	X
Cognition
CANTAB		X			X		X	X
Gait/Turning
APDM		X			X		X	X
Postural Sway
APDM		X			X		X	X
Disability
Gill Disability		X			X		X	X
Other Variables
Short Physical		X			X			X
Performance							X
Battery
Timed Up and Go		X			X		X	X X
Exit Interview